Metagenomi Therapeutics Net Worth 2022-2025 | MGX
Interactive chart of historical net worth (market cap) for Metagenomi Therapeutics (MGX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Metagenomi Therapeutics net worth as of February 05, 2026 is $0.05B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.053B | $0.052B |
| Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $39.914B | 12.38 |
| BridgeBio Pharma (BBIO) | United States | $12.281B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.664B | 18.14 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.831B | 23.18 |
| Bausch Health Cos (BHC) | Canada | $2.125B | 1.51 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.316B | 9.48 |
| Taysha Gene Therapies (TSHA) | United States | $1.208B | 0.00 |
| Personalis (PSNL) | United States | $0.658B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.402B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.180B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |